Xenon Pharmaceuticals Inc. (XENE) › Shares OutstandingXenon Pharmaceuticals Inc. (XENE) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 1.34M2014: 14.18M2015: 14.39M2016: 17.93M2017: 18.00M2018: 25.75M2019: 28.14M2020: 35.01M2021: 51.63M2022: 62.59M2023: 75.37M2024: 76.42M2025: 80.01M80.01M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202580.01M+4.7%202476.42M+1.4%202375.37M+20.4%202262.59M+21.2%202151.63M+47.5%202035.01M+24.4%201928.14M+9.3%201825.75M+43.1%201718.00M+0.4%201617.93M+24.6%201514.39M+1.4%201414.18M+954.7%20131.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share